Skip to content

The effects of Zuojin Pill on the pharmacokinetics of venlafaxine in healthy volunteers

Drug-drug interaction between Zuojin pill and venlafaxine based on CYP2D6 activity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049812
Enrollment
Unknown
Registered
2021-08-10
Start date
2020-07-13
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
21 Years to 26 Years

Inclusion criteria

Inclusion criteria: 1. Aged 19 to 45 years; 2. The body weight is greater than 50kg, and the body mass index [weight kg/ (height m) 2] is between 19 and 24; 3. Good health condition(no significant clinical symptoms or clinically significant abnormal laboratory results).

Exclusion criteria

Exclusion criteria: 1. Allergic physique, with a history of drug or food allergy; 2. Heart, liver, kidney disease or acute or chronic digestive tract disease, angle-closure glaucoma, epilepsy, thyroid disease, blood disease.Or other acute or chronic diseases that may affect drug absorption and metabolism; 3. Positive hepatitis B surface antigen; 4. Drug abusers and tobacco and alcohol abusers; 5. Drinking alcohol within 36 hours before the test; 6. Blood loss or blood donation of more than 200 ml within 3 months before the test; 7. Taking other drugs within 2 weeks before the test; 8. According to the judgment of the researcher, those who are less likely to be included (such as weak body, etc.).

Design outcomes

Primary

MeasureTime frame
blood concentration;

Countries

China

Contacts

Public ContactBo Tan

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

tbot@163.com+86 021 20256536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026